Cyclophilin A – Antizyme Fusion as a Potential HIV-1 Restriction Factor

Loading...
Thumbnail Image

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Title

Cyclophilin A – Antizyme Fusion as a Potential HIV-1 Restriction Factor

Published Date

2013-08-12

Publisher

Type

Thesis or Dissertation

Abstract

During the HIV-1 retroviral life cycle, endogenous cellular proteins serve to both promote and inhibit the retroviral reproductive cycle. Cyclophilin A (CypA) is one such protein that binds the viral capsid. The interaction between CypA and the capsid, especially in the target cell, has been demonstrated to be essential for efficient infection and progression through the HIV-1 reproductive cycle. However, other native proteins inhibit HIV-1 at various stages of the reproductive cycle. For example, TRIM5α catalyzes premature and accelerated capsid uncoating thereby blocking reverse transcription in certain species. Tetherin inhibits budding by tethering the virion to the cell and preventing release. Other proteins exploit a combination of interactions to assist in degradation. TRIMCyp fusions in certain primate species contain a TRIM5α domain fused to a Cyclophilin A domain. The combination results in capsid binding, premature uncoating, and prevention of reverse transcription. Here we attempt to exploit a similar interaction in the creation of a novel HIV-1 restriction factor by fusing CypA to the protein Antizyme-1. Endogenously, Antizyme plays a role in regulating polyamine levels by regulating levels of ornithine decarboxylase (ODC) by mediating ODC degradation via the 26S proteasome. We hypothesized that the combination of the capsid binding CypA domain and the proteasome associated Antizyme domain would result in premature degradation of the viral capsid resulting in reduced viral titer and infectivity. In contrast to our hypothesis, we found that expression of the CypA-Antizyme fusion did not affect viral titer or viral infectivity when expressed in both target and producer cell lines due in part to proteasome mediated degradation of our fusion construct. Despite the negative result, our data suggests future modifications that could be made to our construct to help evade cellular degradation mechanisms and eventually test the full therapeutic potential of the fusion.

Description

Related to

Replaces

License

Series/Report Number

Funding information

Isbn identifier

Doi identifier

Previously Published Citation

Other identifiers

Suggested citation

Williams, Brady. (2013). Cyclophilin A – Antizyme Fusion as a Potential HIV-1 Restriction Factor. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/155338.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.